CTOs on the Move

Kala Pharmaceuticals

www.kalarx.com

 
Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kalarx.com
  • 100 Beaver St. Suite 201
    Waltham, MA USA 02453
  • Phone: 781.996.5252

Executives

Name Title Contact Details

Funding

Kala Pharmaceuticals raised $68M on 04/13/2016
Kala Pharmaceuticals raised $125M on 05/12/2021

Similar Companies

Adherium

Adherium (ASX.ADR) is a global leader in digital health technologies which address sub-optimal medication use in chronic disease.

Cynapsus Therapeutics

Cynapsus Therapeutics Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Airway Therapeutics

Airway Therapeutics is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kleo

Kleo Pharmaceuticals is advancing the field of immunotherapy by developing small molecules that emulate biologics.

Apotex Fermentation

Apotex Fermentation, Inc. is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.